Katrine Bosley serves as Executive at Editas Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Katrine Bosley has executed 51 insider transactions totaling $7.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 8, 2016 involved exercising options for 4,273 shares valued at $0.
Katrine Bosley currently holds 1,204,966 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Katrine Bosley has been a net seller of EDIT stock. They have purchased $0 and sold $7.3M worth of shares.
Katrine Bosley's most recent insider trade was on Feb 8, 2016, when they sold 4,273 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted